Oncogene - Issue - nature.com science feeds Oncogene is one of the world’s leading cancer journals. It is published weekly and covers all aspects of the structure and function of Oncogenes. Oncogene also publishes 8 Reviews issues a year, on a broad range of topics. http://www.nature.com/onc/current_issue/ Nature Publishing Group en Copyright © Nature Publishing Group Oncogene 0950-9232 Copyright © Nature Publishing Group permissions@nature.com Oncogene http://www.nature.com/aj/images/logos_b_o_w/onc.gif http://www.nature.com/onc/ p53 responsive elements in human retrotransposons http://feeds.nature.com/~r/onc/rss/current/~3/zWNwMEHkKBE/onc.2009.246 p53 responsive elements in human retrotransposons

Oncogene 28, 3857 (5 November 2009). doi:10.1038/onc.2009.246

Authors: C R Harris, A DeWan, A Zupnick, R Normart, A Gabriel, C Prives, A J Levine & J Hoh

]]> p53 responsive elements in human retrotransposons C R Harris A DeWan A Zupnick R Normart A Gabriel C Prives A J Levine J Hoh doi:10.1038/onc.2009.246 Oncogene 28, 3857 (5 November 2009) 2009-11-05 Oncogene August 31, 2009 10.1038/onc.2009.246 http://dx.doi.org/10.1038/onc.2009.246 28 44 3857 3865 http://dx.doi.org/10.1038/onc.2009.246 Bone morphogenic protein 6: a member of a novel class of prognostic factors expressed by normal and malignant plasma cells inhibiting proliferation and angiogenesis http://feeds.nature.com/~r/onc/rss/current/~3/Y7L8vbCbGEk/onc.2009.257 Bone morphogenic protein 6: a member of a novel class of prognostic factors expressed by normal and malignant plasma cells inhibiting proliferation and angiogenesis

Oncogene 28, 3866 (5 November 2009). doi:10.1038/onc.2009.257

Authors: A Seckinger, T Meißner, J Moreaux, H Goldschmidt, G M Fuhler, A Benner, M Hundemer, T Rème, J D Shaughnessy, B Barlogie, U Bertsch, J Hillengass, A D Ho, V Pantesco, A Jauch, J De Vos, J F Rossi, T Möhler, B Klein & D Hose

]]> Bone morphogenic protein 6: a member of a novel class of prognostic factors expressed by normal and malignant plasma cells inhibiting proliferation and angiogenesis A Seckinger T Meißner J Moreaux H Goldschmidt G M Fuhler A Benner M Hundemer T Rème J D Shaughnessy B Barlogie U Bertsch J Hillengass A D Ho V Pantesco A Jauch J De Vos J F Rossi T Möhler B Klein D Hose doi:10.1038/onc.2009.257 Oncogene 28, 3866 (5 November 2009) 2009-11-05 Oncogene August 31, 2009 10.1038/onc.2009.257 http://dx.doi.org/10.1038/onc.2009.257 28 44 3866 3879 http://dx.doi.org/10.1038/onc.2009.257 Anticancer DNA intercalators cause p53-dependent mitochondrial DNA nucleoid re-modelling http://feeds.nature.com/~r/onc/rss/current/~3/QsVY9EyP2TA/onc.2009.242 Anticancer DNA intercalators cause p53-dependent mitochondrial DNA nucleoid re-modelling

Oncogene 28, 3880 (5 November 2009). doi:10.1038/onc.2009.242

Authors: N Ashley & J Poulton

]]> Anticancer DNA intercalators cause p53-dependent mitochondrial DNA nucleoid re-modelling N Ashley J Poulton doi:10.1038/onc.2009.242 Oncogene 28, 3880 (5 November 2009) 2009-11-05 Oncogene August 17, 2009 10.1038/onc.2009.242 http://dx.doi.org/10.1038/onc.2009.242 28 44 3880 3891 http://dx.doi.org/10.1038/onc.2009.242 Macrophage-derived IL-1β stimulates Wnt signaling and growth of colon cancer cells: a crosstalk interrupted by vitamin D3 http://feeds.nature.com/~r/onc/rss/current/~3/NUSPD2NyaqQ/onc.2009.247 Macrophage-derived IL-1β stimulates Wnt signaling and growth of colon cancer cells: a crosstalk interrupted by vitamin D3

Oncogene 28, 3892 (5 November 2009). doi:10.1038/onc.2009.247

Authors: P Kaler, L Augenlicht & L Klampfer

]]> Macrophage-derived IL-1β stimulates Wnt signaling and growth of colon cancer cells: a crosstalk interrupted by vitamin D3 P Kaler L Augenlicht L Klampfer doi:10.1038/onc.2009.247 Oncogene 28, 3892 (5 November 2009) 2009-11-05 Oncogene August 24, 2009 10.1038/onc.2009.247 http://dx.doi.org/10.1038/onc.2009.247 28 44 3892 3902 http://dx.doi.org/10.1038/onc.2009.247 The EBV-encoded latent membrane proteins, LMP2A and LMP2B, limit the actions of interferon by targeting interferon receptors for degradation http://feeds.nature.com/~r/onc/rss/current/~3/DSscNwLxU9k/onc.2009.249 The EBV-encoded latent membrane proteins, LMP2A and LMP2B, limit the actions of interferon by targeting interferon receptors for degradation

Oncogene 28, 3903 (5 November 2009). doi:10.1038/onc.2009.249

Authors: K M Shah, S E Stewart, W Wei, C B J Woodman, J D O'Neil, C W Dawson & L S Young

]]> The EBV-encoded latent membrane proteins, LMP2A and LMP2B, limit the actions of interferon by targeting interferon receptors for degradation K M Shah S E Stewart W Wei C B J Woodman J D O'Neil C W Dawson L S Young doi:10.1038/onc.2009.249 Oncogene 28, 3903 (5 November 2009) 2009-11-05 Oncogene August 31, 2009 10.1038/onc.2009.249 http://dx.doi.org/10.1038/onc.2009.249 28 44 3903 3914 http://dx.doi.org/10.1038/onc.2009.249 The prolyl cis/trans isomerase cyclophilin 18 interacts with the tumor suppressor p53 and modifies its functions in cell cycle regulation and apoptosis http://feeds.nature.com/~r/onc/rss/current/~3/sCLK-KnodBc/onc.2009.248 The prolyl cis/trans isomerase cyclophilin 18 interacts with the tumor suppressor p53 and modifies its functions in cell cycle regulation and apoptosis

Oncogene 28, 3915 (5 November 2009). doi:10.1038/onc.2009.248

Authors: N Baum, C Schiene-Fischer, M Frost, M Schumann, K Sabapathy, O Ohlenschläger, F Grosse & B Schlott

]]> The prolyl cis/trans isomerase cyclophilin 18 interacts with the tumor suppressor p53 and modifies its functions in cell cycle regulation and apoptosis N Baum C Schiene-Fischer M Frost M Schumann K Sabapathy O Ohlenschläger F Grosse B Schlott doi:10.1038/onc.2009.248 Oncogene 28, 3915 (5 November 2009) 2009-11-05 Oncogene August 31, 2009 10.1038/onc.2009.248 http://dx.doi.org/10.1038/onc.2009.248 28 44 3915 3925 http://dx.doi.org/10.1038/onc.2009.248 Protein lysate microarray analysis to identify microRNAs regulating estrogen receptor signaling in breast cancer cell lines http://feeds.nature.com/~r/onc/rss/current/~3/t6in6SNs3xA/onc.2009.241 Protein lysate microarray analysis to identify microRNAs regulating estrogen receptor signaling in breast cancer cell lines

Oncogene 28, 3926 (5 November 2009). doi:10.1038/onc.2009.241

Authors: S-K Leivonen, R Mäkelä, P Östling, P Kohonen, S Haapa-Paananen, K Kleivi, E Enerly, A Aakula, K Hellström, N Sahlberg, V N Kristensen, A-L Børresen-Dale, P Saviranta, M Perälä & O Kallioniemi

]]> Protein lysate microarray analysis to identify microRNAs regulating estrogen receptor signaling in breast cancer cell lines S-K Leivonen R Mäkelä P Östling P Kohonen S Haapa-Paananen K Kleivi E Enerly A Aakula K Hellström N Sahlberg V N Kristensen A-L Børresen-Dale P Saviranta M Perälä O Kallioniemi doi:10.1038/onc.2009.241 Oncogene 28, 3926 (5 November 2009) 2009-11-05 Oncogene August 17, 2009 10.1038/onc.2009.241 http://dx.doi.org/10.1038/onc.2009.241 28 44 3926 3936 http://dx.doi.org/10.1038/onc.2009.241 Downregulation of miR-193b contributes to enhance urokinase-type plasminogen activator (uPA) expression and tumor progression and invasion in human breast cancer http://feeds.nature.com/~r/onc/rss/current/~3/iry-f7VmkD0/onc.2009.245 Downregulation of miR-193b contributes to enhance urokinase-type plasminogen activator (uPA) expression and tumor progression and invasion in human breast cancer

Oncogene 28, 3937 (5 November 2009). doi:10.1038/onc.2009.245

Authors: X-F Li, P-J Yan & Z-M Shao

]]> Downregulation of miR-193b contributes to enhance urokinase-type plasminogen activator (uPA) expression and tumor progression and invasion in human breast cancer X-F Li P-J Yan Z-M Shao doi:10.1038/onc.2009.245 Oncogene 28, 3937 (5 November 2009) 2009-11-05 Oncogene August 24, 2009 10.1038/onc.2009.245 http://dx.doi.org/10.1038/onc.2009.245 28 44 3937 3948 http://dx.doi.org/10.1038/onc.2009.245